scholarly journals Basal Cell Carcinoma: 10 Years of Experience

2011 ◽  
Vol 2011 ◽  
pp. 1-5 ◽  
Author(s):  
Emanuele Cigna ◽  
Mauro Tarallo ◽  
Michele Maruccia ◽  
Valentina Sorvillo ◽  
Alessia Pollastrini ◽  
...  
Keyword(s):  
High Risk ◽  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Basal Cell ◽  
Tumor Size ◽  
Study Cohort ◽  
Tumor Characteristics ◽  
Complete Excision ◽  
Upper And Lower Extremities

Introduction. Basal cell carcinoma (BCC) is a locally invasive malignant epidermal tumour. Incidence is increasing by 10% per year; incidence of metastases is minimal, but relapses are frequent (40%–50%). The complete excision of the BCC allows reduction of relapse.Materials and Methods. The study cohort consists of 1123 patients underwent surgery for basal cell carcinoma between 1999 and 2009. Patient and tumor characteristics recorded are: age; gender; localization (head and neck, trunk, and upper and lower extremities), tumor size, excisional margins adopted, and relapses.Results. The study considered a group of 1123 patients affected by basal cell carcinoma. Relapses occurred in 30 cases (2,67%), 27 out of 30 relapses occurred in noble areas, where peripheral margin was <3 mm. Incompletely excised basal cell carcinoma occurred in 21 patients (1,87%) and were treated with an additional excision.Discussion. Although guidelines indicate 3 mm peripheral margin of excision in BCC <2 cm, in our experience, a margin of less than 5 mm results in a high risk of incomplete excisions.

A Challenging Case of Multiply Recurrent Nasal Basal Cell Carcinoma

2011 ◽  
Vol 15 (5) ◽  
pp. 285-289
Author(s):  
Fazilat Mohammed ◽  
Nowell Solish ◽  
Christian A. Murray
Keyword(s):  
High Risk ◽  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Basal Cell ◽  
Locally Advanced ◽  
Complex Case ◽  
Definitive Treatment ◽  
Management Options ◽  
Risk Scale

Background: Basal cell carcinoma (BCC) is the most common human malignancy worldwide and represents a significant cost to health care systems. Most cases occur on the head and neck, and many are successfully treated with relatively simple measures. However, if high-risk or complicated cases are not treated effectively, they may result in considerable disfigurement or morbidity. We report on a patient with a complex nasal basal cell carcinoma (BCC) that failed multiple treatments by electrodesiccation and curettage (EDC). Management strategies for primary and recurrent BCC, including EDC, standard excision, Mohs micrographic surgery (MMS), and radiation therapy, are discussed. This case required extensive resection, and we review the literature for predictive factors of significant subclinical spread. Objective: To present a complex case that illustrates the management options of high-risk, recurrent BCC of the head and neck. Materials and Methods: Case report and review of the literature. Results: MMS offers the lowest recurrence rate in the treatment of recurrent BCC in surgical candidates. A validated risk scale may predict subclinical spread in patients with BCC of the head and neck. Conclusions: BCC can progress to locally advanced disease, necessitating definitive treatment. EDC performed by an experienced dermatologist may offer cure rates comparable to those of surgery in lower-risk BCC. However, in higher-risk tumors, such as recurrent or larger lesions, methods that ensure clear margins should be considered first line, especially in sensitive locations. The routine use of a validated risk scale can better prepare patients and dermatologists for potentially extensive resections. In cases with risk of extensive involvement, strategies to clearly communicate options and progress at all stages of the process should be available.

Multimodality Management of High-Risk Head and Neck Basal Cell Carcinoma Requiring Free Flap Reconstruction

2014 ◽  
Vol 151 (1_suppl) ◽  
pp. P60-P60
Author(s):  
Major B. Burch ◽  
Thomas K. Chung ◽  
Cecelia E. Schmalbach ◽  
Eben L. Rosenthal
Keyword(s):  
High Risk ◽  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Basal Cell ◽  
Free Flap ◽  
Flap Reconstruction ◽  
Free Flap Reconstruction

Multimodality Management of High-Risk Head and Neck Basal Cell Carcinoma Requiring Free-Flap Reconstruction

2015 ◽  
Vol 152 (5) ◽  
pp. 868-873 ◽  
Author(s):  
M. Benjamin Burch ◽  
Thomas K. Chung ◽  
Eben L. Rosenthal ◽  
Cecelia E. Schmalbach
Keyword(s):  
High Risk ◽  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Basal Cell ◽  
Free Flap ◽  
Flap Reconstruction ◽  
Free Flap Reconstruction

The combined effect of CO 2 laser, topical diclofenac 3%, and imiquimod 5% in treating high‐risk basal cell carcinoma

2021 ◽  
Author(s):  
Mohamed El‐Khalawany ◽  
Wael M. Saudi ◽  
Eman Ahmed ◽  
Alsadat Mosbeh ◽  
Ahmed Sameh ◽  
...  
Keyword(s):  
High Risk ◽  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Basal Cell ◽  
Combined Effect ◽  
Topical Diclofenac

scholarly journals 93: Outcome of Radiotherapy for Aggressive forms of Basal Cell Carcinoma of the Head and Neck

2016 ◽  
Vol 120 ◽  
pp. S36
Author(s):  
Anupam Rishi ◽  
Shao Hui Huang ◽  
Yuyao Song ◽  
John Waldron ◽  
Brian O’Sullivan ◽  
...  
Keyword(s):  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Basal Cell

scholarly journals Incomplete excision of basal cell carcinoma (BCC) in the head and neck region: to wait, or not to wait?

2017 ◽  
Vol 34 (6) ◽  
pp. 607-611 ◽  
Author(s):  
Jakub Miszczyk ◽  
Michał Charytonowicz ◽  
Tomasz Dębski ◽  
Bartłomiej Noszczyk
Keyword(s):  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Basal Cell ◽  
Neck Region ◽  
Head And Neck Region ◽  
Incomplete Excision
Sign in / Sign up

Export Citation Format

Share Document